Profil
Jason Slingsby was the founder of ProtAffin Biotechnologie AG, founded in 2005, where the title held was Chief Executive Officer.
Dr. Slingsby is currently Chief Executive Officer at Tozaro Ltd., starting in 2025.
Former jobs include Chief Business Officer at Oxford Biomedica Plc from 2018 to 2023, Principal at InterCel, Inc., Principal at Sosei Co. Ltd., and Member-Supervisory Board at Zytoprotec GmbH.
Education includes a doctorate from Imperial College London and an MBA from London Business School.
Postes actifs de Jason Slingsby
| Sociétés | Poste | Début |
|---|---|---|
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Directeur Général | 09/06/2025 |
Anciens postes connus de Jason Slingsby
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01/05/2023 |
Zytoprotec GmbH
Zytoprotec GmbH Medical/Nursing ServicesHealth Services Provides dialysis renal replacement therapy services | Directeur/Membre du Conseil | - |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Corporate Officer/Principal | - |
InterCel, Inc.
InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Corporate Officer/Principal | - |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Directeur Général | - |
Formation de Jason Slingsby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InterCel, Inc.
InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Communications |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Commercial Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Health Technology |
Zytoprotec GmbH
Zytoprotec GmbH Medical/Nursing ServicesHealth Services Provides dialysis renal replacement therapy services | Health Services |
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Health Technology |
















